7.1 Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus

Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus

Quick Clinical Summary: Pediatric seizures represent acute disruptions of normal cerebral electrical activity resulting from paroxysmal, excessive neuronal discharges. Seizure disorders in children encompass febrile seizures (the most prevalent convulsive event in early childhood), specialized pediatric epilepsy syndromes (including absence seizures and infantile spasms), and the life-threatening neurological emergency of status epilepticus. Nurses must rapidly differentiate benign convulsive events from progressive neurological pathology, execute prioritized bedside airway and injury prevention maneuvers, and adhere to time-critical pharmacological escalation algorithms when seizures exceed 5 minutes.

---

1. Febrile Seizures: Classification, Pathophysiology & Evidence-Based Counseling

Febrile seizures are seizures occurring in infants and young children, typically between 6 months and 5 years of age (peak incidence at 12 to 18 months), associated with a febrile illness (core temperature typically exceeding 38.0°C [100.4°F]) without evidence of intracranial infection (such as meningitis or encephalitis), metabolic derangement, or a prior history of afebrile seizures.

Pathophysiological Mechanisms

The developing pediatric brain exhibits heightened neuronal excitability coupled with immature thermoregulatory mechanisms and incomplete inhibitory gamma-aminobutyric acid (GABA)-ergic neurotransmission. Febrile seizures are triggered by a rapid rate of temperature rise rather than the absolute peak temperature achieved. Endogenous pyrogens (interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha) alter neuronal membrane stability and accelerate neuronal firing in vulnerable cerebral cortices.

Simple vs. Complex Febrile Seizures

Clinical management and prognostic counseling depend entirely on differentiating simple from complex febrile seizures:

Evidence-Based Family Education & Anticipatory Guidance

Witnessing a pediatric seizure is universally traumatic for parents, who frequently believe their child is dying. Compassionate, objective nursing education must include the following evidence-based facts:

1. Prognosis & Cognitive Outcomes: Parents must be strongly reassured that simple febrile seizures do not cause brain damage, intellectual disability, learning disorders, or death.
2. Recurrence Risk: Approximately 30% to 35% of children with a first febrile seizure experience a recurrence during subsequent febrile episodes. The recurrence risk rises to 50% if the first seizure occurred before 12 months of age or with a fever of low peak temperature.
3. The Antipyretic Misconception:

1. Contraindicated Interventions: Cold baths, tepid alcohol sponge baths, or ice packs are strictly prohibited. These measures cause cutaneous vasoconstriction (trapping core heat), intense shivering (which spikes metabolic rate and elevates internal temperature further), and systemic toxicity from transdermal alcohol absorption.
2. Home Seizure Protocol: If a seizure occurs, caregivers should place the child in a lateral side-lying position on a soft surface, remove nearby hard or sharp objects, loosen tight neckwear, avoid restraining movements, never place anything into the child's mouth, record the exact duration, and activate emergency medical services (call 911) if the convulsion exceeds 5 minutes.

---

2. Pediatric Epilepsy Syndromes & Seizure Classifications

Epilepsy is defined by the International League Against Epilepsy (ILAE) as a disease of the brain characterized by at least two unprovoked seizures occurring more than 24 hours apart, or one unprovoked seizure with a high probability (≥60%) of further seizures over the next 10 years.

Generalized Tonic-Clonic Seizures (GTCS)

Generalized tonic-clonic seizures involve bilateral cerebral hemispheres from onset:

• Tonic Phase (10–20 seconds): Sudden loss of consciousness, sustained skeletal muscle contraction, jaw clamping, vocal cord spasm producing an involuntary "epileptic cry," upward eye gaze, and apnea with cyanosis.
• Clonic Phase (30–60 seconds or longer): Rhythmic, alternating, synchronous muscle contraction and relaxation affecting all four extremities, tongue biting (typically lateral border), excessive oral secretions/frothing, and autonomic surge (tachycardia, diaphoresis, pupillary dilation).
• Post-Ictal Phase (minutes to hours): Deep unresponsiveness transitioning to confusion, profound exhaustion, headache, muscle soreness, and retrograde amnesia. Urinary or fecal incontinence is common.

Absence Seizures (Childhood Absence Epilepsy)

Absence seizures (historically termed petit mal) represent non-convulsive generalized epileptic events typically emerging between 4 and 10 years of age:

• Clinical Presentation: Brief, sudden episodes of behavioral arrest and unresponsiveness lasting 5 to 10 seconds. The child stares blankly into space, abruptly stops talking, eating, or walking mid-action, and may exhibit subtle automatisms such as rapid eyelid fluttering or minor lip smacking.
• Distinctive Hallmarks: Consciousness is abruptly terminated and just as abruptly restored. There is no aura, no loss of postural tone (the child does not fall), and no post-ictal confusion; the child resumes the interrupted activity immediately without realizing an event occurred. Episodes occur dozens to hundreds of times daily and are frequently mistaken by teachers and parents for "daydreaming," inattention, or ADHD.
• Diagnostic Provocation & EEG: Absence episodes are reliably provoked in the clinical setting or EEG lab by hyperventilation (deep breathing for 3 minutes) or intermittent photic stimulation. The diagnostic EEG reveals characteristic, generalized, symmetrical 3 Hz (cycles per second) spike-and-wave discharges on a normal background.
• Pharmacological Treatment:
  • Ethosuximide (Zarontin): The first-line drug of choice, specifically blocking T-type voltage-gated calcium channels in thalamocortical neurons with high efficacy and favorable cognitive profile.
  • Valproic Acid (Depakote): Highly effective second-line alternative, preferred if co-existing generalized tonic-clonic seizures are present, though carries risks of hepatotoxicity, pancreatitis, weight gain, and teratogenicity.

Infantile Spasms (West Syndrome)

Infantile spasms represent a catastrophic early-childhood epileptic encephalopathy typically presenting between 3 and 12 months of age (peak onset 4 to 7 months):

• The Diagnostic Triad (West Syndrome):
  1. Epileptic Spasms: Sudden, synchronous contractions of the neck, trunk, and extremities. Most commonly manifest as flexor spasms (sudden forward bending of head and torso with arms flexing and knees pulling upward into the chest, resembling a "jackknife" or "salaam" attack), extensor spasms (head and trunk extension with arm abduction), or mixed flexor-extensor patterns.
  2. Cluster Occurrence: Spasms occur in repetitive clusters of 20 to 100+ contractions spaced seconds apart, most characteristically occurring immediately upon awakening or during transitions from sleep to wakefulness. Parents often mistake these clusters for infant colic, startle reflex, or gastroesophageal reflux (Sandifer syndrome).
  3. Developmental Arrest or Regression: Loss of previously acquired developmental milestones (e.g., loss of social smile, head control, visual tracking, or vocalization).
• Diagnostic EEG Hallmark: Hypsarrhythmia—a wildly chaotic, high-voltage, disorganized background pattern of continuous, multi-focal sharp waves, slow waves, and spikes with no recognizable baseline rhythm.
• Etiology: Can be cryptogenic (unknown) or symptomatic, resulting from hypoxic-ischemic encephalopathy, central nervous system malformations, or genetic conditions—most notably Tuberous Sclerosis Complex (TSC).
• Targeted Pharmacotherapy:
  • Adrenocorticotropic Hormone (ACTH): High-dose natural or synthetic ACTH intramuscular injections; standard first-line therapy for non-TSC cases. Requires monitoring for severe hypertension, hyperglycemia, electrolyte shifts, and immunosuppression.
  • Vigabatrin (Sabril): Irreversible GABA transaminase inhibitor; the undisputed first-line drug of choice for infantile spasms associated with Tuberous Sclerosis Complex. Crucial safety warning: Vigabatrin causes permanent, irreversible peripheral visual field constriction in 30% to 50% of patients, requiring mandatory baseline and serial visual field testing (electroretinography).

Focal Seizures & Todd's Paresis

• Focal Aware Seizures (Simple Partial): Abnormal electrical activity confined to a discrete cortical focus without impairment of consciousness. Manifests with unilateral motor twitching, sensory paresthesias, autonomic flushing, or psychic sensations (aura).
• Focal Impaired Awareness Seizures (Complex Partial): Electrical discharge spreads to alter consciousness. The child displays staring, unresponsiveness, and purposeless involuntary behaviors known as automatisms (lip smacking, chewing, swallowing, picking at clothing, repeating phrases), followed by post-ictal confusion.
• Todd's Paresis: A transient focal neurological deficit—most commonly hemiparesis or monoplegia—affecting the limb(s) involved in the seizure, lasting minutes to 24–48 hours post-ictally before complete resolution. It must be recognized as post-ictal cortical exhaustion rather than an acute ischemic stroke.

Comparative Overview of Pediatric Epilepsy Syndromes

---

3. Acute Seizure Management & Safety Precautions

During an active convulsive seizure, nursing actions center on protecting the child from physical trauma, preserving cerebral oxygenation, and accurately documenting semiology.

Step-by-Step Nursing Protocol During Active Convulsions

Patient Begins Convulsive Seizure
        |
        v
[1. SAFETY FIRST]
- Lower to floor / bed; clear sharp objects; pad bed side rails
- Place in LATERAL RECOVERY POSITION (left or right side-lying)
- Loosen restrictive clothing around neck
        |
        v
[2. PRESERVE AIRWAY & OXYGENATION]
- Allow oral secretions to drain dependent from mouth
- NEVER insert anything into the mouth (NO tongue blades, NO airways)
- Do NOT physically restrain limbs; apply blow-by oxygen if hypoxemic
        |
        v
[3. MONITOR & TIME THE EVENT]
- Note exact time of onset; observe motor progression and eye deviation
- If seizure duration reaches 5 MINUTES -> Activate STATUS EPILEPTICUS Escalation

Critical Actions & Rationale

• Positioning: Immediately turn the child onto their side (lateral recovery position). This allows gravity to pull the tongue forward away from the posterior pharynx and facilitates drainage of saliva, emesis, and tracheobronchial secretions, drastically decreasing the hazard of aspiration pneumonia and upper airway obstruction.
• Protect from Trauma: Clear bedside furniture, lower the hospital bed to its lowest position, and ensure full padding of side rails. Place a soft folded towel or small pillow beneath the child's head if on a hard surface.
• The Absolute Ban on Oral Insertion:

• Do Not Restrain: Never forcefully hold down or restrain flailing extremities. Restraining muscle contractions against resistance causes musculoskeletal tears, joint dislocations, and bone fractures.
• Observation & Documentation: Note the exact start time. Observe and document the following clinical semiology: onset focal or generalized, direction of head/eye turning, presence of tonic vs clonic vs atonic motor components, unilateral or bilateral involvement, respiratory pattern, color changes (pallor, cyanosis), pupillary reaction, incontinence, and duration of the post-ictal phase.

Post-Ictal Nursing Priorities

1. Maintain the lateral recovery position until consciousness is fully restored.
2. Suction oral secretions gently using a flexible suction catheter if airway bubbling or stridor occurs (suction only after active clonic jaw clamping subsides).
3. Apply supplemental oxygen via blow-by or non-rebreather mask to maintain SpO2 ≥95%.
4. Reassess vital signs (heart rate, respiratory rate, blood pressure, oxygen saturation) and assess pupil equality, orientation, speech, and bilateral motor strength to rule out Todd's paresis.

---

4. Status Epilepticus: Definition, Pathophysiology & Emergency Escalation Protocol

Historically, status epilepticus was defined as continuous seizure activity lasting 30 minutes or longer. Current pediatric neurocritical guidelines define Status Epilepticus (SE) operationally using a two-tier timeline:

• Time Point 1 (t1 = 5 minutes): Continuous convulsive seizure activity lasting ≥5 minutes, or two or more distinct seizures without full recovery of baseline consciousness between episodes. Pharmacological intervention must begin immediately at t1 to abort the seizure before systemic decompensation ensues.
• Time Point 2 (t2 = 30 minutes): Seizure activity continuing past 30 minutes, beyond which permanent neuronal injury, pharmacoresistance, and systemic physiological collapse occur.

Cellular Pathophysiology of Prolonged Seizures

During the initial 20 to 30 minutes of continuous seizing, compensatory mechanisms surge: massive sympathetic discharge elevates arterial blood pressure, cerebral blood flow, cardiac output, and blood glucose to meet soaring cerebral metabolic demands. However, after 30 minutes, systemic and cellular decompensation occurs:

1. Receptor Trafficking & Pharmacoresistance: Continuous seizure activity drives rapid internalization and downregulation of synaptic GABA_A receptors, while excitatory NMDA (glutamate) receptors are upregulated and migrate to the synaptic membrane. Consequently, endogenously and exogenously administered benzodiazepines become progressively ineffective as seizures drag on, mandating early administration.
2. Excitotoxicity & Neuronal Death: Massive glutamate release causes excessive calcium influx into neurons, triggering mitochondrial failure, activation of apoptotic proteases, and irreversible hippocampal and cortical neuronal necrosis.
3. Systemic Collapse: Prolonged seizing produces severe lactic and respiratory acidosis, hyperthermia (from sustained muscular work), rhabdomyolysis, hypoglycemia, hyperkalemia, acute pulmonary edema, and cardiac arrhythmias.

Time-Critical Pharmacological Escalation Protocol

0–5 MINUTES: INITIAL STABILIZATION & ASSESSMENT
- Maintain patent airway; high-flow 100% O2 via non-rebreather mask
- Continuous SpO2, ECG, and blood pressure monitoring
- Check bedside point-of-care capillary blood glucose immediately
  * If Hypoglycemic (<60 mg/dL): Administer 10% Dextrose (D10W) 5 mL/kg IV bolus
- Obtain IV or intraosseous (IO) access; draw lab work (electrolytes, AED levels, blood gas)
        |
        v (Seizure continues >= 5 minutes)
5–10 MINUTES: FIRST-LINE THERAPY (RESCUE BENZODIAZEPINES)
- If IV/IO Access Present: IV LORAZEPAM 0.1 mg/kg (max 4 mg) push over 1-2 min
- If NO IV/IO Access Present (Choose one):
  * IM MIDAZOLAM: 0.2 mg/kg (max 10 mg)
  * INTRANASAL (IN) MIDAZOLAM: 0.2 mg/kg (divided between nares using atomizer)
  * RECTAL DIAZEPAM GEL (Diastat): 0.2–0.5 mg/kg PR (locked dosing syringe)
  * BUCCAL MIDAZOLAM: 0.2–0.3 mg/kg
- May repeat identical dose ONCE at 5-10 minutes if seizure persists
- Prepare for airway support (bag-valve-mask, suction) due to apnea risk
        |
        v (Seizure continues >= 10–20 minutes)
10–20 MINUTES: SECOND-LINE THERAPY (NON-SEDATING IV ANTISEIZURE MEDICATIONS)
- Administer full-dose IV second-line agent over 10–15 minutes (Choose one):
  * IV LEVETIRACETAM (Keppra): 60 mg/kg IV (max 4,500 mg)
  * IV FOSPHENYTOIN (Cerebyx): 20 mg PE/kg IV (max 1,500 mg PE) at <=150 mg PE/min
    (Requires continuous ECG and blood pressure monitoring for arrhythmias/hypotension)
  * IV VALPROATE SODIUM (Depacon): 40 mg/kg IV (max 3,000 mg)
    (Contraindicated in known/suspected mitochondrial disease or urea cycle disorders)
  * IV PHENOBARBITAL: 20 mg/kg IV (Drug of choice for neonatal status epilepticus)
        |
        v (Seizure continues >= 20–40+ minutes)
20–40+ MINUTES: THIRD-LINE THERAPY (REFRACTORY STATUS EPILEPTICUS - RSE)
- Prepare for ENDOTRACHEAL INTUBATION and mechanical ventilation
- Transfer to Pediatric Intensive Care Unit (PICU); place arterial line
- Initiate continuous IV anesthetic infusions titrated to burst-suppression on continuous EEG:
  * MIDAZOLAM Continuous Infusion: Loading dose 0.2 mg/kg, then 0.05–2.0 mg/kg/hr
  * PROPOFOL Infusion: (Caution: Propofol Infusion Syndrome with prolonged use)
  * PENTOBARBITAL / THIOPENTAL Infusion (Barbiturate coma)

Detailed Pharmacological Matrix for Pediatric Status Epilepticus

---

5. Non-Pharmacological Management: Ketogenic Diet & Neuromodulation

When pediatric epilepsy proves intractable to medical pharmacotherapy (defined as failure of two appropriately chosen and tolerated anti-seizure medication trials), non-pharmacological interventions are initiated.

The Ketogenic Diet

The ketogenic diet is a high-fat, low-carbohydrate, adequate-protein dietary therapy utilized for medically refractory pediatric epilepsy, demonstrating exceptional efficacy in conditions like GLUT1 deficiency syndrome, pyruvate dehydrogenase deficiency, Dravet syndrome, and Lennox-Gastaut syndrome.

• Dietary Composition: Formulated on a strict weight-based ratio of fat to combined carbohydrate and protein mass, most commonly a 4:1 or 3:1 ratio (e.g., 4 grams of dietary fat for every 1 gram of combined protein and carbohydrate). Fats are derived from heavy whipping cream, butter, mayonnaise, and specialized plant oils (medium-chain triglycerides [MCT]).
• Anticonvulsant Mechanism: Severe carbohydrate restriction forces the liver to metabolize fatty acids into ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone). Ketone bodies cross the blood-brain barrier to serve as an alternative cerebral fuel substrate, enhancing mitochondrial energy production, upregulating GABA synthesis, suppressing central glutamate transmission, and opening inhibitory ATP-sensitive potassium channels.
• Critical Nursing & Clinical Precautions:
  • The Zero-Carbohydrate Rule: Even trace amounts of exogenous carbohydrates will instantly disrupt hepatic ketosis and precipitate breakthrough status epilepticus within hours.
  • Medication Formulation Safety: All oral pediatric medications must be strictly audited. Nurses must never administer liquid syrups, elixirs, chewables, or suspensions containing sorbitol, sucrose, or dextrose. Only sugar-free solutions or crushed non-coated tablets mixed in allowable dietary fats may be given.
  • Intravenous Fluids: Avoid dextrose-containing IV infusions (such as D5W, D5 0.45% NS). Utilize strictly non-dextrose solutions (0.9% Normal Saline) unless treating life-threatening symptomatic hypoglycemia.
  • Long-Term Complication Surveillance: Monitor for nephrolithiasis (kidney stones composed of uric acid or calcium oxalate; prevent with oral potassium citrate), dyslipidemia, prolonged QT interval, constipation, metabolic acidosis, impaired linear bone growth, and osteopenia.

Neuromodulatory Therapies

• Vagus Nerve Stimulation (VNS): A subcutaneously implanted pulse generator in the left chest wall connected to bipolar leads wrapped around the left cervical vagus nerve (CN X). Delivers programmed electrical pulses to the brainstem nucleus tractus solitarius to disrupt epileptogenic networks. Caregivers and patients carry a handheld magnet that, when swept over the generator during a seizure or aura, delivers an immediate on-demand electrical burst to abort the convulsion or shorten post-ictal recovery.